Key result
The transseptal approach for mitral valve surgery showed no significant difference in postoperative permanent pacemaker implantation compared to the left atrial approach.
Why the study?
Does the transseptal approach increase the risk of postoperative permanent pacemaker implantation compared to the left atrial approach in patients undergoing mitral valve surgery?
Does the transseptal approach increase the risk of postoperative permanent pacemaker implantation compared to the left atrial approach in patients undergoing mitral valve surgery?
Answers are grounded in this paper and cite their sources.
An editorial critique emphasizes that despite a recent cohort study showing no significant difference in pacemaker implantation between transseptal and left atrial approaches for mitral valve surgery, significant unadjusted confounding and competing risks limit the reliability of these findings.
Mitral valve diseases are amongst the most common valvular heart pathologies, with surgical repair or replacement of the mitral valve being an established treatment approach [1]. Although the left atrial approach (LA) is conventionally used for mitral valve surgery (MVS), the transseptal (TS) approach has been developed as an alternative approach, including the superior TS and extended TS approaches [2]. The TS approach can be particularly useful in patients requiring concomitant tricuspid valve surgery given that both valves can be accessed using the same incision. However, the relative safety of these 2 approaches has remained a contentious subject, with some studies finding no significant differences between the 2, and others observing an increased risk of postoperative atrial dysrhythmias and permanent pacemaker (PPM) implantation amongst patients undergoing MVS using the TS approach. In 2020, our team published a meta-analysis of 16 studies comparing the TS and LA approaches for MVS in 4537 patients [3]. We observed that the TS approach was associated with significantly higher rates of postoperative atrial fibrillation and PPM implantation. Having detected potential publication bias favouring the TS approach in terms of PPM implantation, the increased risk of PPM implantation associated with the TS approach was probably underestimated already. In this issue of the European Journal of Cardio-Thoracic Surgery, Ntinopoulos et al. [4] reported their investigation of this very subject. In their single-centre retrospective cohort study, they found no significant differences between the TS and LA approaches in terms of postoperative PPM implantation (10.2% in TS vs 7% in LA, unadjusted P = 0.133), which were accompanied by differences in several other postoperative outcomes that generally favoured the LA approach. The lack of significant differences in PPM implantation rates remained consistent across different combinations of MVS and concomitant cardiac surgeries, albeit with a numerically higher rate of PPM implantation in those with isolated MVS without preoperative atrial fibrillation which approached statistical significance (unadjusted P = 0.057). Additionally, this was the first study demonstrating that the surgical approach may have different effects on outcomes depending on the type of MVS, with the LA approach associated with a statistically insignificant trend for higher PPM implantation rate after mitral replacement, and the TS approach with a higher PPM implantation rate after mitral repair. With a total sample size of 677 patients, this was one of the more sizeable cohorts published to date. Despite the apparent disagreement with our meta-analytic results, given the generally low event rates of PPM implantation, most of the studies included in our meta-analysis did not show statistical significance per se [3], and so the findings by Ntinopoulos et al. did not necessarily contradict our prior findings. Nevertheless, we urge caution in interpreting the findings by Ntinopoulos et al. Most glaringly, the TS and LA groups had many important differences in their baseline characteristics, generally showing higher operative risks with the TS group. Despite their obvious confounding effects, no adjustment was performed for baseline differences when comparing outcomes between groups. Confounders are ubiquitous in research and are especially important in observational studies. Multiple methods exist to account for confounders and provide unbiased estimates, such as multivariable regression, propensity score matching, inverse probability of treatment weighting, etc., which may be used alone or in combinations to ensure that statistical analyses are robust [5–8]. In this case, it is unclear how much of the observed differences in outcomes was attributable to the different surgical approaches, and how much was due to the aforementioned confounders. Furthermore, and perhaps more subtly, the significantly higher mortality rate observed in the TS group (9.3% vs 1.5%) may have substantially affected the rate of PPM implantation—this is the well-known issue of competing risk in longitudinal studies, which might not have been obvious in the captioned study as survival analysis, in which competing risk analysis can be addressed readily, was not performed by Ntinopoulos et al. In simple terms, as patients who died could not have PPM implanted subsequently, mortality was a competing event for PPM implantation, and a higher mortality rate may have masked a higher portion of PPM implantation that may have been required had the patients not died. A standard approach to address this issue would be analysing the time-to-event using survival analysis using either the cause-specific hazard model or the Fine–Gray sub-distribution model, with the former being preferable for aetiological research such as the captioned study subject [9]. Several other limitations remain, such as bias by indication and residual confounding due to unobserved confounders, both attributable to the study’s observational nature. In particular, having included a wide range of concomitant procedures and without specifying the types of prosthetic mitral valves and repair techniques/devices used, the study population was highly heterogeneous and prevented meaningful conclusions to be drawn; this appeared to be a common issue with observational studies comparing the TS and LA approaches for MVS [10]. In addition, this study did not clearly define the timeframe of the postoperative period, and the lack of longer-term follow-up further limited the relevance of the study. Notwithstanding the above limitations, this study by Ntinopoulos et al. remains a valuable contribution to the existing literature. Importantly, their finding that the optimal surgical approach may differ depending on the type of MVS warrants further investigation by larger studies of longer follow-up durations. Whilst it would be imprudent to view the findings by Ntinopoulos et al. as definitive answers to this longstanding controversy, the study’s value as a hypothesis-generating piece is undoubted. Ultimately, a randomized controlled trial is required to definitively address the ongoing controversy surrounding the TS and LA approaches for MVS, although the current popularity of minimally invasive valvular surgeries may mean that this is unlikely to be conducted. Given the existing body of evidence, we believe that the results and conclusion of our prior meta-analysis remain valid, but future work in this area, specifically randomized controlled trials investigating the optimal surgical approach for specific types of MVS, may indeed renew our understanding of the subject.
No takes yet. Share an insight, caveat, or question.
Harky et al. (2022) conducted an editorial in Mitral valve diseases (n=677). Transseptal (TS) approach vs. Left atrial (LA) approach was evaluated on Postoperative permanent pacemaker (PPM) implantation (p=0.133). The transseptal approach for mitral valve surgery showed no significant difference in postoperative permanent pacemaker implantation compared to the left atrial approach.
Synapse has enriched 10 related papers. Consider them for comparative context: